Applying machine learning to high-dimensional proteomics datasets for the identification of Alzheimer’s disease biomarkers
Christoffer Ivarsson Orrelid(Region Västra Götaland), Lena Stempfle(Region Västra Götaland), Fredrik Johansson(Institut national de recherche en sciences et technologies du numérique), Henrik Zetterberg(Queen Mary University of London), Johan Gobom(Sahlgrenska University Hospital), Oscar Rosberg(Region Västra Götaland), Newton Mwai(Region Västra Götaland), Sophia Weiner(Institute of Neurobiology)
Cited by 7
Related Papers
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
SymPy: symbolic computing in Python
|PeerJ Computer Science|2017|1.6k
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
|JAMA Neurology|2021|627
A multicentre validation study of the diagnostic value of plasma neurofilament light
|Nature Communications|2021|554
A Practical Guide to Immunoassay Method Validation
|Frontiers in Neurology|2015|541